Next Generation Sequencing Study of clonal Evolution in AML Shows Mutations in RAS-MAPK Signaling Pathway as an Emergent Mechanism of Progression in Low-Intensity Treatments
How to cite: Jiménez-Vicente, C.; Lopez-Guerra, M.; Pérez-Valencia, A. I.; Munarriz, D.; Guijarro, F.; Castaño-Diez, S.; Martinez-Roca, A.; Cortes-Bullich, A.; Cardus, A.; Esteban, D.; Triguero, A.; Tovar, N.; Hernandez, I.; Colomer, D.; Diaz-Beya, M.; Esteve, J. Next Generation Sequencing Study of clonal Evolution in AML Shows Mutations in RAS-MAPK Signaling Pathway as an Emergent Mechanism of Progression in Low-Intensity Treatments. Preprints 2024, 2024010604. https://doi.org/10.20944/preprints202401.0604.v1 Jiménez-Vicente, C.; Lopez-Guerra, M.; Pérez-Valencia, A. I.; Munarriz, D.; Guijarro, F.; Castaño-Diez, S.; Martinez-Roca, A.; Cortes-Bullich, A.; Cardus, A.; Esteban, D.; Triguero, A.; Tovar, N.; Hernandez, I.; Colomer, D.; Diaz-Beya, M.; Esteve, J. Next Generation Sequencing Study of clonal Evolution in AML Shows Mutations in RAS-MAPK Signaling Pathway as an Emergent Mechanism of Progression in Low-Intensity Treatments. Preprints 2024, 2024010604. https://doi.org/10.20944/preprints202401.0604.v1
Abstract
Keywords
Subject
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)